1/4
Export Ready

ICIKINASE 1500000 INJ

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Product details

What are the specifications of this product?

Overview

Product Name: ICIKINASE 15,00,000 IU Injection Generic Name: Streptokinase (1.5 Million IU)Therapeutic Category: Thrombolytic Agent / Cardiovascular MedicineProduct Description: ICIKINASE Injection contains Streptokinase, a thrombolytic (clot-dissolving) medicine used in the management of acute myocardial infarction (heart attack), pulmonary embolism, deep vein thrombosis, and arterial thromboembolism. It works by activating plasminogen into plasmin, which breaks down fibrin clots and restores normal blood flow in blocked vessels. Indications: • Acute Myocardial Infarction (AMI) • Pulmonary Embolism (PE) • Deep Vein Thrombosis (DVT) • Arterial Thrombosis or Embolism • Occluded arteriovenous cannulae Mechanism of Action: • Streptokinase binds with plasminogen to form an activator complex. • This converts plasminogen to plasmin, which dissolves fibrin clots. • Helps restore blood circulation and prevent tissue damage.

Product Description

Dosage & Administration:

• Administered by intravenous infusion only under hospital/ICU settings.

• Standard adult dose for AMI: 1.5 million IU infused over 60 minutes.

• Dosage may vary based on indication and patient condition.

(To be given by trained healthcare professionals only.)



Key Benefits:

• Rapid clot dissolution in life-threatening conditions.

• Reduces risk of mortality in acute heart attack patients.

• Restores blood flow and prevents tissue necrosis.


Packaging:

• Vial containing 15,00,000 IU Streptokinase with sterile diluent.


Storage:

• Store at 2°C – 8°C (Refrigerated).

• Protect from light.

• Do not freeze.


Important Notes:

• For hospital use under strict medical supervision only.

• Contraindicated in patients with active internal bleeding, recent stroke, severe hypertension, or history of hemorrhagic disorders.

• Close monitoring of blood pressure, ECG, and bleeding parameters is mandatory.


Description provided by melizza lifescience.

Specifications

Product Type Injection
Active Substance Streptokinase
IU Strength 1,500,000 IU
Therapeutic Use Thrombolytic for clot dissolution
Route of Administration Intravenous infusion
Indications Specificity AMI, PE, DVT, Arterial Thrombosis, AV Cannulae occlusion
Dosage 1.5 million IU over 60 minutes (standard for AMI)
Packaging Details Single vial with sterile diluent
Storage 2°C – 8°C, no freezing, shield from light
Contraindications Active internal bleeding, recent stroke, severe hypertension, hemorrhagic disorders
Professional Use Strict medical supervision in hospital settings

Use cases

Category Pharmaceuticals > Cardiovascular Drugs > Thrombolytic Agents > Streptokinase Injections
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing ICIKINASE 1500000 INJ. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the recommended administration protocol for ICIKINASE 1,500,000 IU Injection in AMI patients?
A: ICIKINASE is administered via intravenous infusion over 60 minutes, with a standard dose of 1.5 million IU, under strict medical supervision in hospital or ICU settings.
Q: Are there any contraindications for using ICIKINASE in thrombolytic therapy?
A: Yes, it is contraindicated in patients with active internal bleeding, recent stroke, severe hypertension, or hemorrhagic disorders to avoid bleeding complications.
Q: How should ICIKINASE Injection be stored to maintain its efficacy?
A: Store the vial refrigerated between 2°C and 8°C, protect from light exposure, and do not freeze to ensure the stability and potency of the medication.
Q: Can ICIKINASE be used for clearing occluded arteriovenous cannulae?
A: Yes, ICIKINASE is indicated for dissolving clots in occluded arteriovenous cannulae, facilitating restoration of patency.
Q: What monitoring is required during ICIKINASE administration?
A: Continuous monitoring of blood pressure, electrocardiogram (ECG), and bleeding parameters is mandatory to manage therapeutic safety during thrombolysis.
Question not answered? Ask sellers directly — typical response within 4 hours.
ICIKINASE 1500000 INJ
ICIKINASE 1500000 INJ
Price on request · MOQ 1Centimetre